← IPO Calendar

Biocon IPO IPO

Mainline11 Mar 200418 Mar 2004
Open
11 Mar 2004
Close
18 Mar 2004
3
Allotment
Listing
Wed, Apr 7, 2004
Price Band
₹270 to ₹315
Issue Size
1,00,00,000 shares (agg. up to ₹315 Cr)
Listing Date
Wed, Apr 7, 2004
✦ AI Insight

Live Subscription

CategorySubscription (times)
Total32.47x

Restated Financials (₹ Cr.)

Period Ended31 Dec 200331 Mar 200331 Mar 200231 Mar 2001
Assets403.62272.33208.62129.77
Total Income37,24,50,000.0025,55,20,000.0016,49,30,000.0012,35,90,000.00
Profit After Tax86.1135.3121.4914.52
NET Worth212.00124.7386.0156.01
Reserves and Surplus168.48124.5586.0756.01
Total Borrowing65.0368.5666.5338.19
Amount in ₹ Crore

Objects of the Issue

#Issue ObjectsEst Amt (₹ Cr.)
1Land18.40
2Buildings120.00
3Plant and Machinery (including machinery and equipment under erection)260.00
4Other Assets15.00
Total413.40

About Biocon IPO

Incorporated in 1978, Biocon Limited is a Bengaluru-based biotechnology company engaged in biopharmaceuticals, enzymes, custom research, and clinical research services. The company manufactures APIs, specialty enzymes, and provides research and clinical trial solutions through its subsidiaries Syngene International and Clinigene International. The company has a global presence across the United States, Europe, Japan, South America, and Southeast Asia. Its manufacturing and R&D facilities are located in Bengaluru, including fermentation and synthetic manufacturing units supported by proprietary technologies such as PlaFractor. As of December 31, 2003, the company had 854 employees including scientists, researchers, and technical professionals. Competitive Strengths: Strong R&D capabilities Advanced fermentation technology Diversified biotechnology business Flexible manufacturing infrastructure Strong global customer relationships Experienced management team + Read More

Contact Details

Biocon Ltd. Address20th K.M, Hosur RoadElectronic City P.OBengaluru, Karnataka, 560100+91 80 2852 3434bioconipo@biocon.comVisit Website